Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
An overview of the healthcare reforms undertaken in Saudi Arabia and insights into the future of the healthcare industry, including evolving patient demographics, pricing and reimbursement, and development of pharma companies in the Kingdom.
Published By Datamonitor
|
01 Jun 2009 |
$5700
|
Report
|
An overview of risk-sharing agreements and their utilization in the UK, US, Italy and Australia. The pros and cons of risk-sharing agreements are discussed and key strategic recommendations, supported by in depth case study analysis.
Published By Datamonitor
|
16 Jul 2009 |
$3800
|
Report
|
Provides insight, trends, case study analysis and strategic recommendations on how to optimize a pharmaceutical brand's marketing channel mix through using traditional and eMedia channels.
Published By Datamonitor
|
27 Aug 2009 |
$3800
|
Order this report by October 22nd 2010 and receive a 50% discount
To take advantage of this offer enter Promo Code Orphan50 when prompted in the checkout
More information
|
Report
|
Overview of orphan drug strategies in the seven major markets, providing insight into developmental and commercial drivers and resistors, and Pharma's growing focus on targeting niche indications as the primary care blockbuster era nears its end.
Published By Datamonitor
|
02 Oct 2009 |
$3800
|
Report
|
Detailed analysis of the monoclonal antibody segment, encompassing market dynamics, key therapy areas, geography, technology and target types through to 2014, evaluating the strategies companies are using to capitalize on this lucrative market
Published By Datamonitor
|
02 Nov 2009 |
$7600
|
Report
|
Diversification is one strategy Big Pharma is using to contend with the oncoming patent cliff, however, Datamonitor has analyzed ten sectors within healthcare and concluded that remaining pharma-focused will lead to maximum revenue growth.
Published By Datamonitor
|
12 Nov 2009 |
$7600
|
Report
|
A comparative analysis of leading pharmaceutical company sales dynamics over the period 200514
Published By Datamonitor
|
27 Nov 2009 |
$7600
|
Report
|
Revenue and financial performance analysis of the 22 largest Big Pharma M&A events since 1995.
Published By Datamonitor
|
10 Dec 2009 |
$7600
|
Report
|
An overview of M&A trends for the top 150 global pharmaceutical companies during 2008 and 2009 with discussion of the drivers of recent deals, plus case study analysis of key M&As.
Published By Datamonitor
|
17 Dec 2009 |
$11400
|
Report
|
A historical (02-08) and forecast (08-14) sales overview of the PharmaVitae universe by drug delivery classification.
Published By Datamonitor
|
22 Dec 2009 |
$7600
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.